News Focus
News Focus
icon url

cabel

02/12/15 2:48 PM

#91380 RE: govorchin #91379

"Among patients enrolled in the 8th cohort of the ongoing Kevetrin trial, results showed SIGNIFICANT ENHANCEMENT OF P21 EXPRESSION IN 50% OF THESE PATIENTS!!!. These findings represents a positive signal for the potential efficacy of Kevetrin in the treatment of cancer."

Does this not mean that Cohort 8 was tested for p21,...???

Anyone,..?
icon url

DaubersUP

02/12/15 3:39 PM

#91386 RE: govorchin #91379

Exactly Gov. That is all we need to hear...the trial is advancing as they have seen and would expect...from preclinical data.!

For many of us, we understand that...and are in prior to the people that need to see actual results to believe. We got CTIX shares at a HUGE discount because we see what others can't. Just like B. The facts were hinted throughout PRs and presentations, yet people can't see it without the QIDP...then the QIDP was granted and boom...people see. Now we all see that B is a slam dunk at a 98% plus approval rate per NR, however people will wait for the FDA to grant breakthrough or rolling review etc...and a deal with pharma...and then they jump in. At 10+ a share.

I'm a gambling man. And I've never seen such an advantage over the house as I do here. Time is the only barrier. IMO.
icon url

Whoops

02/12/15 4:35 PM

#91387 RE: govorchin #91379

Yep Gov. Leo has already mentioned it. Its hard to tell what will be appreciated on our current exchange. For some they will need to see the hard numbers which should be coming out soon- proof if you will. They got an incredible response of p21 at tiny doses and soon we will find out what happened after very exciting.

Really looking forward to that article presentation coming up and wonder if they can get that in to the late-breaking section at ASCO.

Be well